Gapping up In reaction to strong earnings/guidance: GLUU +20.6%, (will partner with Katy Perry on the development of a new mobile game ), DATA +16.5%, KIRK +12.7%, INUV +10.7%, EXAR +10.6%, GRA +6.4%, AFOP +6.1%, PRCP +5.6%, NICE +5.3%, LCI +4.6%, GPRE +4.5%, CONN +4.5%, MPWR +4.2%, BLL +4%, SNN +3.9%, CATM +3.4%, LB +3.3%, FORM +3%, BGC +2.4%, LAZ +2.3%, PSEC +1.8%, SNY +1.8%, CX +1.7%, SIRI +1.4%, SNY +1.4%, DNKN +1.3%, PRGO +1.3%, BOOT +1.2%, VMC +1.2%, RRTS +0.9%, WFT +0.9%, TEVA +0.9%
M&A news: HSP +35.3% (Pfizer (PFE) to acquire hospira for $90 a share), BT +5.8% (agrees definitive terms to acquire EE for GBP12.5 bln to create the UK's leading communications provider), PFE +3.1% (to acquire HSP)
Select financial related names showing strength: HERO +7.4%, CRZO +6.9%, GDP +4.8%, BBEP +4.1%, MPET +3.7%, OAS +3.3%, SDRL +2.4%, BP +1.4%, RDS.A +0.9%
Other news: SMRT +16.4% (announced a $5 per share special dividend) FXCM +9.2% (cont vol pre-mkt), FTR +8.5% (attributed to potential Verizon (VZ) deal to buy its Wireline assets), GENE +7.6% (announced yesterday that its Nasdaq deficiencies had successfully been remediated), RXDX +4.3% (receives orphan drug designation from FDA for Entrectinib for the treatment of molecularly defined subsets of non-small cell lung cancer), NGD +3.9% (reported FY14 gold production of 380,135 ounces; sees FY15 gold production of 390-430k ounces), GALE +3.7% (announces that its partner, Orexo AB, has filed a patent infringement lawsuit in United States District Court against Actavis Laboratories (ACT) and Andrx Corporation), OCN +3.6% (discloses company update, expects to record a loss in the fourth quarter of 2014 and for the total year), TWTR +3% (Bloomberg report Twitter has stuck a deal with Google to make tweets easier to search through the search engine), YNDX +2.1% (released a new app that helps drivers in Moscow find a parking space and pay for the service without leaving their car), SHAK +2.1% (cont vol pre-mkt), SE +2.1% (Spectra Energy and Spectra Energy Partners (SEP) announce 2015 business outlook and financial plan), AST +1.8% (announces public offering of common stock; price and size details not disclosed), GSK +1.7% (following peer SNY earnings), TASR +1.7% (announced the purchase of 700 AXON Flex body cameras as well as 700 five-year Unlimited and RMS Integration licenses to EVIDENCE.com by the Maricopa County Sheriff's Office ), GRPN +1.4% (plans to sell stake in Ticket Monster, according to reports)
Analyst comments: BRCD +3.6% (upgraded to Buy from Sell at Citigroup ), FITB +1% (upgraded to Buy from Neutral at BofA/Merrill )